Key Takeaways
- Sharp revenue recovery, margin rebound: Revenue rose 49.7% YoY as raw material cost pressures eased and realizations improved to ₹135/kg, pulling the company out of a painful period of high input costs and Chinese dumping.
- The raw material story is turning: A cut in import duty on Crude Soybean Oil and the apparent end of Chinese dumping are together expected to improve both availability and cost of key feedstocks, setting up a better H2.
- A novel product holds the biggest optionality: A small-capacity plant for a new fatty-acid derivative, described as a "very, very huge market" if the process succeeds, is set to start up after Diwali, though management warns it will take time to run smoothly.
- Europe slowdown is a near-term drag: The Isostearic Acid-driven cosmetics business faces headwinds from a slowing European market, but management is betting on a structural recovery given only four global players exist.
- What to watch next quarter: Whether the new product plant starts up on schedule and how quickly it stabilizes, the pace of capacity utilization improvement from the current 60-65%, and any further softening in raw material prices.
Raw Material & Input Cost Recovery
- The core problem is easing: Management stated the company "suffered badly" because a 27% duty on crude oils made raw materials too expensive; as reasonableness has returned, performance has started improving.
- Import duty cut: Duty on Crude Soybean Oil was reduced from 16.5% to 11%, which is expected to prompt refiners to process more soybean oil, improving raw material availability substantially and softening prices somewhat.
- Dumping has stopped: Chinese dumping, which management believes was driven by export incentives from the Chinese government, has now ceased; management does not expect it to restart and believes Fairchem was able to sustain and compete through the episode.
- Rupee tailwind: Depreciation of the rupee also helped realization.
- No market share lost: Management was explicit that the issue was solely raw material costs rising substantially, not any loss of competitive position.
- Import duty risk contained: Management does not expect the government to increase import duty in the near future because inflation is currently very high and raising oil rates would hurt the economy.
Jariwala: "Basically, we suffered and we were saying time and again that we suffered badly because of the 27% duty on the crude oils, which made our raw materials too expensive. That's the reason and once the reasonableness has started coming in, we have started improving. We have not lost market share. There's nothing negative about the thing. It was only the raw material costs had gone up substantially."
Realization & Volume Trajectory
- Realization climbing: Realization improved from ₹106/kg in Q2 FY26 to ₹130/kg in Q1 FY27 to ₹135/kg in Q2 FY27, driven by lower raw material costs and higher finished product prices.
- Capacity utilization still low: Currently at 60-65%, with management targeting a 5% improvement every quarter as raw material availability improves.
- Production ramp on track: Management confirmed they are on line with the plan to increase production by 5% every quarter and increase exports.
- Domestic support: Lower imports of dimer acid helped improve realization and supported operating margins in the domestic market.
- Cost discipline holding: Fuel costs, salary costs, and other manufacturing costs have remained stable despite inflation; higher processing volumes achieved while maintaining cost levels.
New Product: The Big Optionality
- What it is: A novel-technology derivative of fatty acids with both import-substitution and export potential; management described the addressable market as "very, very huge" if the process succeeds.
- Timing and ramp-up: A small-capacity plant is expected to commence in the October-December quarter, after Diwali, but management does not expect it to function without hiccups from day one because it is a novel technology and process that will take its own time to stabilize.
- Capex gated on success: No immediate expansion plans exist; management is waiting for the new product to prove itself, and only once satisfied will it commit to the capex that success would require.
- Other product updates: A PFAD bypass product has been commercialized, and energy-saving and cost-reduction work is already complete.
Jariwala: "Oh, if our process succeeds, then it's a very, very huge market. It's a huge, huge market."
Exports & Trade Environment
- US exports stalled by freight: All spadework for US exports has been completed, but high freight costs from India to the US are preventing movement; exports will commence once freight rates stabilize.
- Trade policy tailwinds possible: Reduction in US tariffs along with potential benefits from free trade agreements with the UK, Europe, and the Union could provide a more favorable trade environment for exports.
- Isostearic Acid approvals progressing: Export approval cycles for Isostearic Acid and other products are over or at one stage of getting over across many places.
- Europe slowdown a near-term drag: The European market has started slowing down due to strife and issues in the region, and the cosmetic business is expected to get affected in the near term.
Isostearic Acid & Cosmetics
- Near-term pressure from Europe: Slowing European demand is expected to affect the cosmetic business in the near term, though management sees no need for any knee-jerk reaction.
- Structural demand conviction: Management's long-term thesis rests on two facts: cosmetics cannot be made without Isostearic Acid, and there are only four players globally. Once Europe stabilizes, the approved, good-quality product will start delivering results.
Jariwala: "You cannot make cosmetic without Isostearic. And there are just four players in the world. So I mean, it's going to happen."
Margins & Capital Allocation
- Margin aspiration: Management would "love to see" EBITDA margins of 15-18% and believes current margins should be maintainable, with efforts to improve as much as possible.
- No debt reduction planned: Once business stabilizes at higher levels, management will think about utilizing operating cash flow in the best interest of shareholders, but there is no plan to reduce debt as of now.
- Land transaction completed: A land purchase from the promoter for ₹12 crore was completed in the current period; the land was already in use for operations and a workers' colony.
- Raw material mix guarded: Management declined to disclose what percentage soybean constitutes of the raw material mix, calling it proprietary.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Capacity utilization improvement | 5% improvement every quarter from current 60-65% | Quarterly, ongoing |
| New product plant startup | Small-capacity plant to commence operations; will take its own time to run smoothly | October-December quarter (post-Diwali) |
| US export commencement | Exports to begin once freight rates stabilize | No date (gated on freight) |
| Revenue growth trajectory | 5% to 10% growth every quarter | Annual, ongoing |
| Capex decision | Will commit to capex only after new product proves successful | Gated on new product success |
| EBITDA margin target | Aspiration to reach 15-18% | No timeline given |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Revenue from operations | ₹167 cr, +49.7% YoY |
| H1 FY27 revenue from operations | ₹343 cr, +41.4% YoY |
| EBITDA margin | 10.5% |
| H1 FY27 EBITDA margin | 10.3% |
| Net profit | ₹10.2 cr |
| H1 FY27 net profit | ₹21.2 cr |
| Realization | ₹135/kg, up from ₹130/kg in Q1 FY27 and ₹106/kg in Q2 FY26 |
| Raw material processed | 12,200 tons |
| Sales volume | 12,300 tons |
| H1 FY27 raw material processed | 24,600 tons |
| H1 FY27 sales volume | 25,800 tons |
| Capacity utilization | 60% to 65%, expected to improve with better raw material availability |
| Working capital cycle | ~100 days; 90–100 days for domestic, higher for exports |
| Import duty on Crude Soybean Oil | Reduced to 11% from 16.5% |